Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 first-in-human study of CCX872-B in healthy volunteers
NL-OMON37040Phase 1Active, not recruiting
- Sponsor
- ChemoCentryx
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in diabetic glomerulosclerosis comparing CCX872-B with Placebo (2 arms). Started Oct 2012; status: active, not recruiting.
02
Drugs
ccx872-b
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on NL-OMON37040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37040.